Quantum-Si to Attend the 2024 American Society of Human Genetics Annual Meeting
Quantum-Si Incorporated (NASDAQ: QSI), known as The Protein Sequencing Company™, is excited to announce its participation at the upcoming 2024 American Society of Human Genetics (ASHG) Annual Meeting. This event is a significant platform for sharing advancements in genetic research, and Quantum-Si will be hosting a special talk that highlights the transformative role of Next-Generation Protein Sequencing (NGPS) in genomics research.
Presentation Overview
The anticipated presentation, titled "From Prediction to Protein: Validating Transcriptomics Data with Quantum-Si’s Next-Generation Protein Sequencing Technology," will feature the expertise of Quantum-Si alongside a distinguished academic researcher. The focus will be on the crucial intersection between transcriptomics and proteomics in genetic research.
Featurd Presenters
Dr. Meredith Carpenter, Head of Scientific Affairs at Quantum-Si, will present alongside Dr. Colette Felton, a talented postdoctoral scholar from the Angela Brooks laboratory at the University of California, Santa Cruz. Dr. Felton's research is centered around crafting computational tools that enhance the prediction capabilities of splice variants and other genetic alterations, particularly in long-read RNA sequencing data. The collaboration seeks to demonstrate how Quantum-Si’s NGPS technology serves not just as a research tool but as a validation mechanism for ensuring the predictions made through transcriptomics.
Enhancing Genomic Data Accuracy
In their joint presentation, the two researchers will delve into how Quantum-Si’s cutting-edge technology aids in confirming the predictions made from genomic and transcriptomic data. By validating the actual presence, quantity, and modifications of proteins, this technology helps paint a more accurate picture of genetic diversity.
Insights from RNA Sequencing
During her segment of the discussion, Dr. Felton will elaborate on the latest breakthroughs in long-read RNA sequencing. This method has proved effective in identifying various novel genetic variants, including single nucleotide variants (SNVs), insertions, deletions, and gene fusions, especially in the context of cancer research. Applying NGPS to confirm these variants at the protein level is critical to comprehending their implications in disease processes.
The Role of Quantum-Si in Scientific Partnerships
Jeff Hawkins, CEO of Quantum-Si, remarked on the significance of NGPS technology, stating, "This innovative approach empowers researchers to authenticate predicted proteoforms at the protein level, aligning seamlessly with evolutionary breakthroughs in transcriptomics. Our partnership with UC Santa Cruz exemplifies our commitment to furthering multi-omics research through impactful collaborations that promote scientific advancement."
Meet Quantum-Si at ASHG 2024
Attendees of the ASHG 2024 event are invited to visit booth #465 to engage with the Quantum-Si team and learn more about their pioneering technologies and applications in genomic research.
About Quantum-Si Incorporated
Quantum-Si is dedicated to revolutionizing the expanding field of proteomics. With the help of their Platinum® instrument and Next-Generation Protein Sequencing™ capabilities, the company aims to enhance proteomic research, drug development, and diagnostics far beyond what conventional methods can achieve. To discover more about Quantum-Si’s innovative technologies and research solutions, interested parties are encouraged to visit their official website or connect through social media platforms.
Frequently Asked Questions
What is Quantum-Si's role in the ASHG 2024 event?
Quantum-Si will participate by presenting on their Next-Generation Protein Sequencing technology and how it enhances genomic research.
Who are the presenters at Quantum-Si's talk?
Dr. Meredith Carpenter and Dr. Colette Felton will co-present their findings and insights during the event.
What is the focus of Quantum-Si's presentation?
The presentation focuses on validating transcriptomics data through protein sequencing technology.
Where can attendees find Quantum-Si at ASHG 2024?
Attendees can visit booth #465 to interact with the Quantum-Si team.
What technologies does Quantum-Si specialize in?
Quantum-Si specializes in Next-Generation Protein Sequencing™ and other advanced proteomic tools to enhance scientific research.
